IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- EBITDA, 2025
- −$222M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$222M | — |
| 2024 | −$304M | — |
| 2023 | −$109M | — |
| 2022 | −$36M | — |
| 2021 | −$24M | — |
| 2020 | −$12M | — |
| 2019 | −$9.7M | — |
Immunome, Inc.
$20.90+0.01 (+0.05%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$222M | — |
| 2024 | −$304M | — |
| 2023 | −$109M | — |
| 2022 | −$36M | — |
| 2021 | −$24M | — |
| 2020 | −$12M | — |
| 2019 | −$9.7M | — |